Chief Financial Officer · Immunovant, Inc. · Common Stock
Side
M
Value
$159K
Shares
10.0K
Price
$15.9
Executed
Jun 26, 2026
Disclosed
Jun 26, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jun 26 executedJun 26, 2026 disclosed
IMVT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+4 / 25
$159K reported value · 4.0% of prior position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Girao Tiago filed this Form 4 reporting a option exercise of IMVT on Jun 26, 2026. It became public on Jun 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Girao Tiagocik:0001618670
Issuer
Immunovant, Inc.cik:0001764013
Revision history · 0
No field has changed since this record was first ingested.
